Henk Wisselink

Dr. Henk Wisselink

PhD
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

15 June 2006 in Veterinary Microbiology
Verified
Journal Article
Closed access
LSL Silva
L Silva
CBC Baums
C Baums
TRT Rehm
T Rehm
Henk WisselinkHenk Wisselink
Henk Wisselink
RGR Goethe
R Goethe
PVP Valentinweigand
P Valentinweigand

14 April 2001 in Veterinary Record
Verified
Journal Article
Closed access
PDF file
Henk WisselinkHenk Wisselink
Henk Wisselink
UVU. Vecht
U. Vecht
HSH. E. Smith
H. E. Smith
NSN. Stockhofe‐Zurwieden
N. Stockhofe‐Zurwieden
The efficacy of a muramidase‐released protein (MRP) and extracellular factor (EF) vaccine in preventing infection and disease in pigs challenged either with a homologous or a heterologous Streptococcus suis serotype 2 strain (MRP+EF+) was compared with the efficacy of a vaccine containing formalin‐killed bacterin of S suis serotype 2 (MRP+EF+). The enhancement of the immune response by different adjuvants (a water‐inoil emulsion [wo] and an aluminium hydroxide‐based adjuvant [AHJ) and their side effects were also studied. The MRP and EF were purified by affinity chromatography. Pigs were vaccinated twice at three weeks and six weeks of age and challenged intravenously with virulent S suis serotype 2 strains (MRP+EF+) at eight weeks of age. At challenge, the pigs vaccinated with MRP+EF/WO had high anti‐MRP and anti‐EF titres and were protected as effectively as pigs vaccinated with wo‐formulated vaccines with bacterin. Eight of the nine pigs survived the challenge and almost no clinical signs of disease were observed. The titres obtained with the MRP+EF/AH vaccine were low and only two of the five pigs were protected. Pigs vaccinated with either MRP or EF were less well protected; three of the four pigs died after challenge but the clinical signs of disease were significantly less severe than those observed in the placebo‐vaccinated pigs. The protective capacity of the bacterin/AH vaccine was very low, and the mortality among these pigs was as high as in the placebovaccinated pigs (80 per cent). Postmortem histological examination revealed meningitis, polyserositis and arthritis in the clinically affected pigs. The results demonstrate that a subunit vaccine containing both MRP and EF, formulated with the wo adjuvant, protected pigs against challenge with virulent S suis type 2 strains.

1 December 2001 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
MBM. Baele
M. Baele
KCK. Chiers
K. Chiers
LDL.A. Devriese
L.A. Devriese
HSH.E. Smith
H.E. Smith
Henk WisselinkHenk Wisselink
Henk Wisselink
FHFreddy Haesebrouck
Freddy Haesebrouck
Aims: To investigate Gram‐positive nasal and tonsillar microbial flora of piglets before and after weaning. Methods and Results: The nasal and tonsillar Gram‐positive bacterial flora of 20 non‐wean...

1 January 2011 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
AGAstrid De Greeff
Astrid De Greeff
Henk WisselinkHenk Wisselink
Henk Wisselink
FBFreddy M de Bree
Freddy M de Bree
CSConstance Schultsz
Constance Schultsz
CBChristoph G Baums
Christoph G Baums
HSHilde E Smith
Hilde E Smith
Streptococcus suis is a zoonotic pathogen that causes infections in young piglets. S. suis is a heterogeneous species. Thirty-three different capsular serotypes have been described, that differ in virulence between as well as within serotypes.

8 September 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IDIngrid Van Dixhoorn
Ingrid Van Dixhoorn
IRInonge Reimert
Inonge Reimert
JMJenny Middelkoop
Jenny Middelkoop
JBJ. Elizabeth Bolhuis
J. Elizabeth Bolhuis
Henk WisselinkHenk Wisselink
Henk Wisselink
NSNorbert Stockhofe-Zurwieden
Norbert Stockhofe-Zurwieden
Until today, anti-microbial drugs have been the therapy of choice to combat bacterial diseases. Resistance against antibiotics is of growing concern in man and animals. Stress, caused by demanding environmental conditions, can reduce immune protection in the host, influencing the onset and outcome of infectious diseases. Therefore psychoneuro-immunological intervention may prove to be a successful approach to diminish the impact of diseases and antibiotics use. This study was designed to investigate the effect of social and environmental enrichment on the impact of disease, referred to as “disease susceptibility”, in pigs using a co-infection model of PRRSV and A. pleuropneumoniae. Twenty-eight pigs were raised in four pens under barren conditions and twenty-eight other pigs were raised in four pens under enriched conditions. In the enriched pens a combination of established social and environmental enrichment factors were introduced. Two pens of the barren (BH) and two pens of the enriched housed (EH) pigs were infected with PRRSV followed by A. pleuropneumoniae, the other two pens in each housing treatment served as control groups. We tested if differences in disease susceptibility in terms of pathological and clinical outcome were related to the different housing regimes and if this was reflected in differences in behavioural and immunological states of the animals. Enriched housed pigs showed a faster clearance of viral PRRSV RNA in blood serum (p = 0.014) and histologically 2.8 fold less interstitial pneumonia signs in the lungs (p = 0.014). More barren housed than enriched housed pigs developed lesions in the lungs (OR = 19.2, p = 0.048) and the lesions in the barren housed pigs showed a higher total pathologic tissue damage score (p<0.001) than those in enriched housed pigs. EH pigs showed less stress-related behaviour and differed immunologically and clinically from BH pigs. We conclude that enriched housing management reduces disease susceptibility to co-infection of PRRSV and A. pleuropneumoniae in pigs. Enrichment positively influences behavioural state, immunological response and clinical outcome in pigs.